Literature DB >> 12482838

Apolipoprotein E and lipoprotein lipase increase triglyceride-rich particle binding but decrease particle penetration in arterial wall.

Adam E Mullick1, Richard J Deckelbaum, Ira J Goldberg, Maysoon Al-Haideri, John C Rutledge.   

Abstract

OBJECTIVE: Liver-derived apolipoprotein E (apoE) decreases atherosclerosis without altering the circulating concentrations of plasma lipoproteins. We evaluated the effects of apoE and lipoprotein lipase (LpL) on the interactions of triglyceride-rich particles (TGRPs) in the arterial wall. METHODS AND
RESULTS: Quantitative fluorescence microscopy was used to study the interactions of TGRPs (25- to 35-nm diameter) in the arterial wall. Carotid arteries were harvested from rats, placed in a perfusion chamber, and perfused with fluorescently labeled TGRPs. In the absence of apoE or LpL, 1,1'-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine-TGRP (100 microg neutral lipid/mL) was poorly retained in the arterial wall. The addition of either apoE (10 microg/mL) or LpL (10 microg/mL) increased TGRP accumulation 220% and 100%, respectively. This effect was attenuated by heparin (10.0 IU/mL). Histological analyses of cross sections from these vessels demonstrate that in the absence of apoE or LpL, there is deep penetration of lipid into the arterial wall. With the addition of either apoE or LpL, arterial wall penetration of TGRP is blocked.
CONCLUSIONS: These results demonstrate that although apoE and LpL increase arterial wall accumulation of TGRPs, these proteins also reduce the penetration of TGRPs into the arterial wall. We postulate that this may represent a novel antiatherogenic property of apoE and LpL.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12482838     DOI: 10.1161/01.atv.0000040221.70377.19

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  7 in total

Review 1.  The heparan sulfate proteoglycan grip on hyperlipidemia and atherosclerosis.

Authors:  Philip L S M Gordts; Jeffrey D Esko
Journal:  Matrix Biol       Date:  2018-05-24       Impact factor: 11.583

2.  Heparin binding triggers human VLDL remodeling by circulating lipoprotein lipase: Relevance to VLDL functionality in health and disease.

Authors:  Shobini Jayaraman; Antonio Pérez; Inka Miñambres; Jose Luis Sánchez-Quesada; Olga Gursky
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2021-10-02       Impact factor: 4.698

3.  n-3 fatty acids reduce arterial LDL-cholesterol delivery and arterial lipoprotein lipase levels and lipase distribution.

Authors:  Chuchun L Chang; Toru Seo; Mika Matsuzaki; Tilla S Worgall; Richard J Deckelbaum
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-02-05       Impact factor: 8.311

4.  The GPIHBP1-LPL complex is responsible for the margination of triglyceride-rich lipoproteins in capillaries.

Authors:  Chris N Goulbourne; Peter Gin; Angelica Tatar; Chika Nobumori; Andreas Hoenger; Haibo Jiang; Chris R M Grovenor; Oludotun Adeyo; Jeffrey D Esko; Ira J Goldberg; Karen Reue; Peter Tontonoz; André Bensadoun; Anne P Beigneux; Stephen G Young; Loren G Fong
Journal:  Cell Metab       Date:  2014-04-10       Impact factor: 27.287

Review 5.  GPIHBP1: an endothelial cell molecule important for the lipolytic processing of chylomicrons.

Authors:  Stephen G Young; Brandon S J Davies; Loren G Fong; Peter Gin; Michael M Weinstein; André Bensadoun; Anne P Beigneux
Journal:  Curr Opin Lipidol       Date:  2007-08       Impact factor: 4.776

Review 6.  Inflammatory Links Between Hypertriglyceridemia and Atherogenesis.

Authors:  Xueying Peng; Huaizhu Wu
Journal:  Curr Atheroscler Rep       Date:  2022-03-11       Impact factor: 5.967

7.  Apolipoprotein E derived from CD11c+ cells ameliorates atherosclerosis.

Authors:  Manuela Sauter; Reinhard J Sauter; Henry Nording; Chaolan Lin; Marcus Olbrich; Stella Autenrieth; Christian Gleissner; Martin Thunemann; Nadia Otero; Esther Lutgens; Zouhair Aherrahrou; Dennis Wolf; Lars Zender; Sven Meuth; Robert Feil; Harald F Langer
Journal:  iScience       Date:  2021-12-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.